News

RevitasNOW includes broader analytics of rebate effects with wholesalers and managed markets

It's still just speculation that the No. 1 US wholesaler will make a bold bid for access to European and other international markets

Veeva Network for compiling physician master-data lists and related prescriber data has initial customers

While FDA dithers on regulatory guidance, state efforts to anticipate biosimilar regulation are mostly being rejected

IAG Cargo's Heathrow facility is up and running; FedEx has begun construction at its Memphis hub

The Medicare Part D switchover of 2007 is only a partial proxy for what the healthcare system will experience in the next several years

Study surveys recent orphan-drug approvals, finding good alignment between Orphan Drug Act goals and achievements

Results of a survey panel by QPharma, presented at PDMA Sharing Conference, show a wide spread of reactions and concerns over agg-spend rules

Radiopharmaceuticals critical to diagnostic imaging will become more available from a Zevacor facility

Canadian Blood Service works with manufacturers and nonprofits to expand Factor VIII supplies to the developing world

Mark Walchirk of McKesson joins executive board

New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare

Bill includes voluntary oversight by FDA of outsourced compounded pharmaceuticals, national distributor licensure, and a timetable for serialization and drug tracking

Regulation of compounding pharmacies will be included in the new Drug Quality and Security Act

A compromise bill is in the works, say Washington sources

Cells, tissues and regenerative-medicine materials, in biobanking or clinical research, are the focus

Feasibility study with US Oncology Research will evaluate the practicality of multiple biomarker testing

UDIs will be in place starting in late 2014, and rolling out over the next four years thereafter

The perfect pharmaceutical product would be a pill or injection that, once taken, has a near-immediate beneficial effect.

For specialty pharmaceuticals, the connection between manufacturer, payer and patient is the rising crop of hub services

Regulatory compliance remains the top concern globally, but security and spoilage are high in the Asia/Pacific region

Abbott Labs is tops in healthcare equipment

CRM-software training company expands its international presence

The Biofeedback services closes the loop on patient outcomes

Sept. 23 is the deadline for implementing new restrictions on sending industry-sponsored refill reminders to patient

Rising costs of cancer care, and a lack of tools to manage quality of care, are highlighted in new Institute of Medicine report

DrugChannels.net draws out specialty pharmacies from the annual list; only some work directly with manufacturers

But their evidence seems to validates industry's claim that coupons are not generics killers